Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Hong Liu, Sara Huerta-Yepez, Ph.D, Clara M. Rivera-Pazos, MD, Ma de Lourdes Cabera-Muñoz, MD, Stavroula Baritaki, Ph.D, Suzie Vardanyan, Manuel L Penichet, M.D., Ph.D., Haiming Chen, James R. Berenson, MD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3991.

https://doi.org/10.1182/blood.V118.21.3991.3991

Published: 2011

Journal Articles

Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy,

Gabriel G Vega, MDVZ, Mario I Vega, PhD, Sara Huerta-Yepez, Ph.D., Ali Jazirehi, PhD, Hector Mayani, PhD, Otoniel Martinez-Maza, PhD, Sherie Morrison, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3499.

https://doi.org/10.1182/blood.V118.21.3499.3499

Published: 2011

Journal Articles

Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM): RKIP Overexpression and RKIP Phosphorylation Is Common in MM Tumor Cells

Stavroula Baritaki, Ph.D., Sara Huerta-Yepez, Ph.D., Ma de Lourdes Cabera-Muñoz, MD, Clara Rivera-Pazos, MD, Kam Yeung, Ph.D., Manuel L Penichet, M.D., Ph.D., Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2729.

https://doi.org/10.1182/blood.V112.11.2729.2729

Published: 2008

Journal Articles

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

Sara Huerta-Yepez, Ph.D., Clara Rivera-Pazos, MD, Massimo Libra, Stavroula Baritaki, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2730.

https://doi.org/10.1182/blood.V112.11.2730.2730

Published: 2008

Journal Articles

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Rosendo Luria-Pérez, Ph.D., Yolanda Rocio Peña-Alonso, M.D., Daniel Dimitri Hernández-Cueto, B.Sc., Altagracia Maldonado-Valenzuela, B.Sc., Guillermina Juliana Baay-Guzmán, B.Sc., Guadalupe Diaz-Elizondo, B.Sc., Luis Andrés Lara-Martínez, B.Sc., Glenda Juárez-Caballero, M.D., Mario I. Vega, PhD, Benjamin Bonavida, PhD, Sara Huerta-Yepez, Ph.D.

Blood (2008) 112 (11): 5308.

https://doi.org/10.1182/blood.V112.11.5308.5308

Published: 2008

Journal Articles

Nitric Oxide Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis through Induction of RKIP, Inhibition of YY1 and Upregulation of DR5.

Stavroula Baritaki, PhD, Alina Katsman, Sara Huerta-Yepez, Ph.D., Kam C. Yeung, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 4604.

https://doi.org/10.1182/blood.V108.11.4604.4604

Published: 2006

Journal Articles

Over Expression of YY1 and RKIP in Multiple Myeloma (Cell Lines and MM Tissues).

Stavroula Baritaki, PhD, Sara Huerta-Yepez, Ph.D., Alina Katsman, Kam C. Yeung, Ph.D., Devasis Chatterjee, Ph.D., Haiming Chen, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 5035.

https://doi.org/10.1182/blood.V108.11.5035.5035

Published: 2006

Journal Articles

Rituximab-Mediated Inhibition of the p38 MAPK and NF-κB Survival Pathways In Vitro and Validation in Nude Mice Bearing the Raji B-NHL Tumor.

Mario I. Vega, PhD, Sara Huerta-Yepez, Ph.D., Melisa A. Martinez-Paniagua, Cesar G. Bonilla, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 2373.

https://doi.org/10.1182/blood.V108.11.2373.2373

Published: 2006

Journal Articles

Rituximab-Mediated Sensitization of B-NHL Cells Lines to TRAIL-Induced Apoptosis: Involvement of YY1 Suppression and DR5 Upregulation.

Mario I. Vega, PhD, Sara Huerta-Yepez, Ph.D., Stavroula Baritaki, Ph.D., Cesar Bonilla-Gonzalez, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 2387.

https://doi.org/10.1182/blood.V108.11.2387.2387

Published: 2006

Journal Articles

Induction of RKIP and Inhibition of the Transcription Repressor YY1 in B-NHL by the Novel Proteasome Inhibitor NPI-0052 and Sensitization to TRAIL-Induced Apoptosis.

Eriko Suzuki, Sara Huerta-Yepez, Ph.D., Stavroula Baritaki, Ph.D., Michael Palladino, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 2391.

https://doi.org/10.1182/blood.V108.11.2391.2391

Published: 2006

Journal Articles

Rituximab-Mediated Inhibition of the Constitutive NIK/IKK/IκB/NF-κB Signaling Pathway in Non-Hodgkin’s Lymphoma (NHL) B-Cell Lines: Role in Chemo-Sensitization.

Ali R. Jazirehi, Ph.D., Sara Huerta-Yepez, Ph.D., Genhong Cheng, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2004) 104 (11): 288.

https://doi.org/10.1182/blood.V104.11.288.288

Published: 2004

Journal Articles

Rituximab-Mediated Inhibition of the Transcription Repressor Yin-Yang 1 (YY1) in NHL B Cell Lines: Upregulation of Fas Expression and Sensitization to Fas-Induced Apoptosis.

Mario I. Vega, Ph.D., Sara Huerta-Yepez, Ph.D., Ali R. Jazirehi, Ph.D., Hermes Garban, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2004) 104 (11): 287.

https://doi.org/10.1182/blood.V104.11.287.287

Published: 2004

Journal Articles

Rituximab-Mediated Molecular Cell Signaling Via CD20 in B-NHL Cell Lines: Autonomy from Cross-Linking with Tumor FcRs.

Mario I. Vega, Ph.D., Sara Huerta-Yepez, Ph.D., Paul Chinn, Ph.D., Hari Hariharan, Ph.D., Nabil Hanna, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2004) 104 (11): 3404.

https://doi.org/10.1182/blood.V104.11.3404.3404

Published: 2004

NARROW

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy,

Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM): RKIP Overexpression and RKIP Phosphorylation Is Common in MM Tumor Cells

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Nitric Oxide Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis through Induction of RKIP, Inhibition of YY1 and Upregulation of DR5.

Over Expression of YY1 and RKIP in Multiple Myeloma (Cell Lines and MM Tissues).

Rituximab-Mediated Inhibition of the p38 MAPK and NF-κB Survival Pathways In Vitro and Validation in Nude Mice Bearing the Raji B-NHL Tumor.

Rituximab-Mediated Sensitization of B-NHL Cells Lines to TRAIL-Induced Apoptosis: Involvement of YY1 Suppression and DR5 Upregulation.

Induction of RKIP and Inhibition of the Transcription Repressor YY1 in B-NHL by the Novel Proteasome Inhibitor NPI-0052 and Sensitization to TRAIL-Induced Apoptosis.

Rituximab-Mediated Inhibition of the Constitutive NIK/IKK/IκB/NF-κB Signaling Pathway in Non-Hodgkin’s Lymphoma (NHL) B-Cell Lines: Role in Chemo-Sensitization.

Rituximab-Mediated Inhibition of the Transcription Repressor Yin-Yang 1 (YY1) in NHL B Cell Lines: Upregulation of Fas Expression and Sensitization to Fas-Induced Apoptosis.

Rituximab-Mediated Molecular Cell Signaling Via CD20 in B-NHL Cell Lines: Autonomy from Cross-Linking with Tumor FcRs.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only